Related Experiment Video
Updated: May 30, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Guidelines for designing and reporting clinical trials in vitiligo
Urbà González1, Maxine Whitton, Viktoria Eleftheriadou
1Department of Dermatology, Research Unit for Evidence-Based Dermatology, Hospital Plató, Barcelona, Spain. 24998ugc@comb.cat
Objective:
To create guidelines for randomized controlled trials (RCTs) investigating interventions used in the management of vitiligo.
Participants:
Guideline developers included authors (clinicians, patient representatives, and a statistician) of the Cochrane systematic review "Interventions for Vitiligo" plus the coordinator of the vitiligo priority-setting partnership at the Centre of Evidence-Based Dermatology at the University of Nottingham.
Evidence:
The guidelines are based on the assessment of the quality of design and reporting of RCTs evaluating interventions for vitiligo included in the 2010 update of the Cochrane systematic review "Interventions for Vitiligo."
Consensus Process:
We reviewed and commented on the sources of bias in existing RCTs on interventions for vitiligo (selection bias, blinding assessment, attrition bias, characteristics of participants, interventions, and outcomes) based on the findings of the Cochrane review, and we used open discussion on guideline drafts focusing on the study question (participants, interventions, and outcomes), study design (research methods), and reporting.
Conclusions:
Much opportunity exists for improving the design and reporting of vitiligo clinical trials. The proposed guidelines will help overcome methodologic challenges faced when conducting RCTs to answer treatment questions.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Bioavailability Study Design: Healthy Subjects Versus Patients
Blinding
Dosage Regimens: Designs and Approaches
